Actualité

European Network to Cure Amyotrophic Lateral Sclerosis Meeting 2018

  • Recherche,
  • Santé-Sciences-Technologie,
Date(s)

du 20 juin 2018 au 22 juin 2018

Lieu(x)
Oxford
Grande-Bretagne

A more productive time in neuroscience research, bringing with it the realistic expectation of therapeutic advances for those living with ALS

Welcome Address

Dear colleagues,

We are proud to host the 2018 European Network to Cure ALS (ENCALS) meeting and welcome you to Oxford. There has never been a more productive time in neuroscience research, bringing with it the realistic expectation of therapeutic advances for those living with ALS. This ENCALS meeting is by far the largest to date, with more than 400 registered delegates. From the nearly 250 submitted abstracts, we have been able to build an exciting programme of cutting-edge research, interspersed with engaging plenary speakers from around the world. The Oxford ALS Centre was founded in 2001 through the Motor Neurone Disease Association’s pioneering Care Centre programme that now comprises more than 20 UK regional specialist clinics. Our research programme spans the single cell to the complete nervous system. We try to integrate this work into clinical care as much as possible through a close partnership with those living with ALS.

Oxford itself has a long and rich cultural history. Its University is one of oldest in the world, with teaching recorded as far back as the 11th Century. It operates as a federation of more than 40 self-governing Colleges and Halls scattered around the city, responsible for more than 23,000 students among a total city population of 150,000. Among the University’s alumni are 29 Nobel laureates and 27 UK Prime Ministers. The very strong academic ties with European and wider international partners continue to be greatly valued.

The growth of the ENCALS meeting ensures it is a large administrative task. We are very grateful to our support team, particularly Akke Albada and Simone Vugts from the ENCALS office, plus Lynn Ossher and Niki Andrew at the Oxford end.

Research conferences are a catalyst for productivity and therapeutic advancement ultimately. Discussing ideas, comparing notes, developing existing and new collaborations are important elements in building a sense of global community and shared purpose. We wish you an enjoyable as well as productive meeting.

Martin Turner & Kevin Talbot

MORE INFORMATION
 

The members of Neurogenomics and Neuronal Physiopathology will present their research projects on ALS: From basics to clinics.

  • TDP-43 protein aggregation in Amyotrophic Lateral Sclerosis: a role for the post-translational modification SUMOylation - Cindy Maurel, Anna Chami, Rose-Anne Thépault, Sylviane Marouillat, Céline Brulard, Hélène Blasco, Philippe Corcia, Christian Andres, Patrick Vourc’h.

  • Combined metabolomics and lipidomics analyzes of fibroblasts from ALS patients - Blasco H, Veyrat-Durebex C, Caudron P, Bris C, Bocca C, Chupin S, Corcia P, Vourc’h P, Funalot B, Andres CR, Lenaers G, Couratier P, Reynier P.

  • Prognostic value of serum creatinine in ALS patients: A meta-analysis - Débora Lanznaster, Frank Patin, Philippe Corcia, Christian Andres, Patrick Vourc’h, Theodora Angoulvant, Hélène Blasco.

Contact :
Prof. Philippe Corcia :